Lilly Catalyze360

Lilly Catalyze360 is an external innovation unit of Eli Lilly and Company designed to accelerate the development of breakthrough therapies through strategic partnerships with biotech companies. The unit provides a comprehensive suite of offerings, including venture capital investment through Lilly Catalyze360-Ventures and R&D expertise through Lilly Catalyze360-ExploR&D. By leveraging Lilly's extensive drug discovery and development capabilities, the initiative aims to support early-stage companies in advancing their pipelines from discovery to clinical proof-of-concept. This collaborative model allows Lilly to access external innovation while providing partners with the resources and scale of a global pharmaceutical leader.